Michael Willis
Overview
Explore the profile of Michael Willis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willis M, Nilsson A, Lwin Z, Bradvik G, Prelaj A
J Manag Care Spec Pharm
. 2025 Jan;
31(1):69-81.
PMID: 39745843
Background: Non-small cell lung cancer (NSCLC) presents a formidable global health challenge owing to significant morbidity, high mortality rates, and substantial economic burden. Recent advances in targeted therapies and immunotherapies...
2.
Zhao T, Tew M, Feenstra T, van Baal P, Willis M, Valentine W, et al.
Appl Health Econ Health Policy
. 2024 Sep;
22(6):861-869.
PMID: 39283475
Objective: This study leveraged data from 11 independent international diabetes models to evaluate the impact of unrelated future medical costs on the outcomes of health economic evaluations in diabetes mellitus....
3.
Willis M, Nilsson A, Kellerborg K, Lwin Z, Prelaj A
J Manag Care Spec Pharm
. 2024 Aug;
30(9):1041-1056.
PMID: 39213147
Background: Budget impact models (BIMs) forecast the financial implications of adopting new technologies and the potential need for budget reallocation, thus playing a crucial role in reimbursement decisions. Despite the...
4.
Altunkaya J, Li X, Adler A, Feenstra T, Fridhammar A, Keng M, et al.
Value Health
. 2024 Jul;
27(10):1338-1347.
PMID: 38986899
Objectives: The Mount Hood Diabetes Challenge Network aimed to examine the impact of model structural uncertainty on the estimated cost-effectiveness of interventions for type 2 diabetes. Methods: Ten independent modeling...
5.
Willis M, Colonetti E, Bakir A, Alame Y, Annetts M, Aygin D, et al.
PLoS One
. 2024 Jun;
19(6):e0305276.
PMID: 38875242
Background: Peripheral Intravenous Cannulas (PIVCs) are frequently utilised in the Emergency Department (ED) for delivery of medication and phlebotomy. They are associated with complications and have an associated cost to...
6.
Willis M, Carey M, Foxe J, Jones J, Smith N, Vaidya V
Eur J Neurosci
. 2023 Aug;
58(5):3199-3205.
PMID: 37533328
No abstract available.
7.
Prelaj A, Ganzinelli M, Trovo F, Roisman L, Pedrocchi A, Kosta S, et al.
Clin Lung Cancer
. 2023 Mar;
24(4):381-387.
PMID: 36959048
Although immunotherapy (IO) has changed the paradigm for the treatment of patients with advanced non-small cell lung cancers (aNSCLC), only around 30% to 50% of treated patients experience a long-term...
8.
Willis M, Darwiche G, Carlsson M, Nilsson A, Wohlin J, Lindgren P
Blood Press Monit
. 2023 Feb;
28(2):86-95.
PMID: 36729897
Purpose: Hypertension is a leading causeof premature death worldwide and a major public health problem. This study investigated the long-term effects (>1 year) of digital hypertension monitoring by home blood...
9.
Gottlieb M, Wang R, Yu H, Spatz E, Montoy J, Rodriguez R, et al.
Clin Infect Dis
. 2023 Jan;
76(11):1930-1941.
PMID: 36705268
Background: Most research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants focuses on initial symptomatology with limited longer-term data. We characterized prevalences of prolonged symptoms 3 months post-SARS-CoV-2 infection...
10.
Stafford S, Bech P, Fridhammar A, Miresashvili N, Nilsson A, Willis M, et al.
Appl Health Econ Health Policy
. 2022 Apr;
20(4):623.
PMID: 35441978
No abstract available.